Treatment burden, adherence, and quality of life in children with daily GH treatment in France.

Coutant, Régis; Tauber, Maithé; Demaret, Béatrice; Henocque, Robin; Brault, Yves; Montestruc, François; Chassany, Olivier; Polak, Michel

Coutant, Régis; Tauber, Maithé; Demaret, Béatrice; Henocque, Robin; Brault, Yves; Montestruc, François; Chassany, Olivier; Polak, Michel.

Afiliação

Coutant R; Department of Pediatric Endocrinology and Diabetology, Reference Center for Rare Pituiatry Diseases, University Hospital of Angers, Angers, France.
Tauber M; Reference Center for the Prader-Willi syndrome and other rare obesities with feeding disorders (PRADORT), Children Hospital, CHU Toulouse, Toulouse, France.
Demaret B; Pediatric team of the Clinical Investigation Center 9302/INSERM, Hospital of Children, Toulouse, France.
Henocque R; Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM UMR1291 - CNRS UMR5051 - Université Toulouse III, Toulouse, France.
Brault Y; GRANDIR - French Growth Disorders Association, Asnières-sur-Seine, France.
Montestruc F; Pfizer France, Paris France.
Chassany O; Pfizer France, Paris France.
Polak M; eXYSTAT, Malakoff, France.

Endocr Connect ; 12(4)2023 Apr 01.

Article em En | MEDLINE | ID: mdl-36866786

Palavras-chave

growth hormone deficiency; patient-reported outcomes; quality of life; recombinant growth hormone; treatment burden

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Aspecto: Patient_preference Idioma: En Revista: Endocr Connect Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google